Wandering Monk
Well-Known Member
By now we have global evidence that the vaccines are safe and effective against hospitalization and death (7 billion doses administered globally.) I have been a big advocate of vaccination, but this is damnable.
One of the companies hired by Pfizer to conduct trials on its Covid vaccine has been accused of falsifying trial data. A recent report by the British Medical Journal also points out the inability of the FDA to adequately investigate whistleblower complaints.
This better get fixed! Independent labs not funded by the company producing the drug would be a good start.
Heads need to roll.
"But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails."
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
One of the companies hired by Pfizer to conduct trials on its Covid vaccine has been accused of falsifying trial data. A recent report by the British Medical Journal also points out the inability of the FDA to adequately investigate whistleblower complaints.
This better get fixed! Independent labs not funded by the company producing the drug would be a good start.
Heads need to roll.
"But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails."
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial